CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Radiofrequency tissue remodeling for female stress urinary incontinence

This policy governs coverage of transvaginal and transurethral radiofrequency (RF) tissue remodeling procedures for treatment of female stress urinary incontinence for Blue Cross Blue Shield - Rhode Island members.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyRadiofrequency tissue remodeling for female stress urinary incontinence

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateFeb 7, 2009

Next Review DateMar 20, 2024

Key ActionDo not submit prior authorization; prior authorization is not applicable for this policy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Not coveredTransvaginal and transurethral RF procedures

NonePrior authorization

2024-03-20Last review

53860Noted code

Coverage Determinations

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Not Medically Necessary

Not Medically Necessary / Not Covered

ALL of the following

Transvaginal radiofrequency bladder neck suspension is not medically necessary / not covered for Commercial Products because the evidence is insufficient to determine the effects of the technology on health outcomes.
Transurethral radiofrequency tissue remodeling (including transurethral radiofrequency micro-remodeling of the female bladder neck and proximal urethra for stress urinary incontinence) is not medically necessary / not covered for Commercial Products because the evidence is insufficient to determine the effects of the technology on health outcomes.
For Medicare Advantage Plans, the following coding and coverage guidance applies: CPT code 53860 (Transurethral, radiofrequency micro-remodeling of the female bladder neck and proximal urethra for stress urinary incontinence) is not covered. There is no specific CPT code for transvaginal radiofrequency bladder neck suspension; CPT code 53899 (unlisted procedure, urinary system) would be used if billed, and the procedure is considered not covered.

Coverage Criteria: For Medicare Advantage members, CPT code 53860 (transurethral radiofrequency micro-remodeling of the female bladder neck and proximal urethra for stress urinary incontinence) is not covered. For transvaginal radiofrequency bladder neck suspension there is no specific CPT code; CPT 53899 (unlisted procedure, urinary system) would be reported if performed and is not covered. For Commercial Products, both transvaginal radiofrequency bladder neck suspension and transurethral radiofrequency tissue remodeling are considered not medically necessary as the evidence is insufficient to determine the effects of the technology on health outcomes.

Provider Actions and Operational Notes

Prior Authorization

Not applicable

Documentation Required

Benefit Verification Required

Benefits and eligibility can vary by subscriber contract and employer agreement. Providers should verify member benefits, coverage limitations, and eligibility prior to scheduling services. The member's subscriber agreement, member certificate, or employer agreement supersedes this policy. For services determined to be not medically necessary or non-covered benefits, providers may not bill the member unless the member has been informed and has agreed in writing to pay out-of-pocket. Refer to participation agreements for billing provisions.

Note

Conservative Therapy Context

Conservative, non‑surgical therapies are the recommended initial management for stress urinary incontinence. Typical conservative options include pelvic floor muscle (Kegel) exercises, biofeedback, electrical stimulation, and periurethral bulking agents. Surgical interventions (including bladder suspension procedures) are generally considered when conservative therapy has failed to provide adequate symptom control.

Denial Risk

Coverage Denial Triggers

Transvaginal radiofrequency bladder neck suspension and transurethral radiofrequency tissue remodeling are considered not medically necessary; these procedures are not covered due to insufficient evidence of benefit. CPT 53860 (transurethral radiofrequency micro-remodeling) is not covered for Medicare Advantage and is considered not medically necessary for commercial products. There is no specific CPT for transvaginal RF bladder neck suspension; CPT 53899 (unlisted procedure, urinary system) would be used if billed, and may be denied as not medically necessary.

Procedural Definitions

inv-11: Transvaginal RF bladder neck suspension — definition and key elements

ApproachTransvaginal system: a vaginal incision is made lateral to the urethra to expose the endopelvic fascia; RF energy is applied over the fascia in a slow sweeping manner to cause blanching and tissue shrinkage.

Target anatomyEndopelvic fascia supporting the bladder neck and urethra to reduce urethral and bladder neck hypermobility.

Energy delivery and effectNonablative radiofrequency energy is used to shrink and stabilize endopelvic fascia, improving support for the urethra and bladder neck.

Setting and anesthesiaPerformed as an outpatient procedure, typically under general anesthesia.

Coding noteNo specific CPT code listed for the transvaginal RF bladder neck suspension; transvaginal procedures would be reported using CPT 53899 (unlisted urinary procedure) per the policy coding group.

inv-12: Transurethral RF tissue remodeling (Renessa and similar) — probe, needles, anatomy, mechanism

Probe and needlesA specially designed transurethral probe with four deployable needles is passed through the urethra into the bladder neck and proximal urethra; needles are deployed from the probe into the tissue.

Energy delivery parametersRadiofrequency energy is delivered for 60 seconds per application, generating tissue temperatures of approximately 65–75°C to produce focal microscopic collagen denaturation.

Treatment pattern and mechanismThe procedure is repeated (described as 9 times) to denature collagen at multiple tissue sites (reported as 36 sites) to reduce urethral hypermobility via tissue remodeling.

Target anatomyBladder neck and upper (proximal) urethra where collagen denaturation is intended to tighten/support the urethral zone.

Coding and coverage stanceCPT 53860 (transurethral radiofrequency micro-remodeling of the female bladder neck and proximal urethra) is specifically listed in the policy coding group and is not covered for Medicare Advantage plans and considered not medically necessary for Commercial Products.

Background and Clinical Context

Stress urinary incontinence is involuntary urine loss with increased intra-abdominal pressure (for example with coughing or exertion) and commonly affects adult women. Initial management is conservative and may include pelvic floor muscle exercises, biofeedback, electrical stimulation, and periurethral bulking agents. Surgical bladder suspension procedures are treatment options when conservative care fails. Radiofrequency (RF) techniques — delivered either via a transvaginal approach to the bladder neck or a transurethral approach into the bladder neck and proximal urethra — are intended to shrink and stabilize endopelvic fascia or denature collagen to reduce urethral hypermobility, but these RF approaches lack sufficient evidence of clinical effectiveness per the policy.